GENENTECH, INC.

DC

Biotechnology

Active 2008–2026. The register lists this client once for every firm that files on its behalf; all 18 of its records are shown together here.

Filings
459
Filed By
18
Reported In-House
—
Reported By Firms
$21,970,000

Filings

YearFirmPeriodAmountDoc
2026 HARBINGER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 YC CONSULTING, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 MARSHALL & POPP, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 KING & SPALDING LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2026 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 TIBER CREEK HEALTH STRATEGIES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
$60,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 CORNERSTONE GOVERNMENT AFFAIRS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 HARBINGER STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2026 TODD STRATEGY GROUP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
Page 1 of 46  ·  459 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings